Primary |
Nausea |
14.7% |
Product Used For Unknown Indication |
13.3% |
General Anaesthesia |
10.0% |
Hyperemesis Gravidarum |
9.3% |
Prophylaxis Of Nausea And Vomiting |
8.7% |
Vomiting |
6.0% |
Anaesthesia |
4.7% |
Drug Use For Unknown Indication |
4.7% |
Premedication |
4.7% |
Chemotherapy |
4.0% |
Pain |
4.0% |
Depression |
2.7% |
Prophylaxis |
2.7% |
Analgesic Therapy |
2.0% |
Anxiety |
2.0% |
Breast Cancer |
1.3% |
Colon Cancer Stage Iv |
1.3% |
Colon Neoplasm |
1.3% |
Constipation |
1.3% |
Large Cell Lung Cancer Recurrent |
1.3% |
|
Ventricular Tachycardia |
15.4% |
Torsade De Pointes |
12.8% |
Vomiting |
10.3% |
Nausea |
7.7% |
Tearfulness |
7.7% |
Somnolence |
5.1% |
Tremor |
5.1% |
Ventricular Extrasystoles |
5.1% |
Brain Death |
2.6% |
Chest Discomfort |
2.6% |
Chills |
2.6% |
Congenital Musculoskeletal Anomaly |
2.6% |
Constipation |
2.6% |
Coronary Artery Disease |
2.6% |
Diarrhoea |
2.6% |
Drug Exposure During Pregnancy |
2.6% |
Drug Ineffective |
2.6% |
Drug Interaction |
2.6% |
Dyskinesia |
2.6% |
Electrocardiogram Qt Prolonged |
2.6% |
|
Secondary |
Product Used For Unknown Indication |
21.5% |
Prophylaxis Of Nausea And Vomiting |
16.9% |
Drug Use For Unknown Indication |
7.1% |
Nausea |
6.2% |
Premedication |
5.2% |
Breast Cancer |
5.0% |
Analgesic Therapy |
3.9% |
Drug Exposure During Pregnancy |
3.8% |
Synovial Sarcoma |
3.8% |
Anaesthesia |
3.6% |
Vomiting |
3.3% |
Prophylaxis |
2.8% |
Small Intestine Carcinoma |
2.8% |
Non-small Cell Lung Cancer Stage Iii |
2.5% |
Pain |
2.5% |
Lung Neoplasm Malignant |
2.4% |
Rectal Cancer |
1.9% |
Bone Sarcoma |
1.7% |
Hypertension |
1.6% |
Diffuse Large B-cell Lymphoma |
1.4% |
|
Drug Exposure During Pregnancy |
8.6% |
Completed Suicide |
7.1% |
Electrocardiogram T Wave Inversion |
7.1% |
Transaminases Increased |
7.1% |
Vomiting |
7.1% |
Caesarean Section |
5.7% |
Laryngeal Dyspnoea |
5.7% |
Venoocclusive Liver Disease |
5.7% |
Drug Interaction |
4.3% |
Encephalopathy |
4.3% |
Paraesthesia |
4.3% |
Rash Pruritic |
4.3% |
Sense Of Oppression |
4.3% |
Serotonin Syndrome |
4.3% |
Sinus Arrhythmia |
4.3% |
Unresponsive To Stimuli |
4.3% |
Acute Myocardial Infarction |
2.9% |
Anaphylactic Shock |
2.9% |
Cytolytic Hepatitis |
2.9% |
Diarrhoea |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
35.7% |
Drug Use For Unknown Indication |
20.1% |
Nausea |
6.2% |
Pain |
5.3% |
Non-small Cell Lung Cancer |
4.0% |
Prophylaxis |
3.9% |
Colorectal Cancer |
2.9% |
Hypertension |
2.8% |
Prophylaxis Of Nausea And Vomiting |
2.8% |
Vomiting |
2.5% |
Constipation |
1.6% |
Anxiety |
1.5% |
Gastrooesophageal Reflux Disease |
1.5% |
Breast Cancer |
1.4% |
Multiple Myeloma |
1.4% |
Premedication |
1.4% |
Colon Cancer |
1.3% |
Acute Myeloid Leukaemia |
1.3% |
Colorectal Cancer Metastatic |
1.2% |
Acute Lymphocytic Leukaemia |
1.1% |
|
Vomiting |
24.2% |
Renal Failure Acute |
7.7% |
Weight Decreased |
6.5% |
Sepsis |
5.5% |
Thrombocytopenia |
5.5% |
Nausea |
5.2% |
Pyrexia |
4.8% |
Pulmonary Embolism |
4.5% |
Anaemia |
4.2% |
Cerebrovascular Accident |
3.9% |
Tachycardia |
3.9% |
Renal Failure |
3.2% |
White Blood Cell Count Decreased |
3.2% |
Death |
2.9% |
Colitis |
2.6% |
Decreased Appetite |
2.6% |
Urinary Tract Infection |
2.6% |
Venoocclusive Disease |
2.6% |
Diarrhoea |
2.3% |
Febrile Neutropenia |
2.3% |
|
Interacting |
Hepatosplenic Candidiasis |
36.4% |
Depression |
18.2% |
Nausea |
18.2% |
Anaesthesia |
9.1% |
Hypotonia |
9.1% |
Vomiting |
9.1% |
|
Atrioventricular Block Second Degree |
40.0% |
Sinoatrial Block |
40.0% |
Drug Interaction |
20.0% |
|